The protective effect of glycyrrhizic acid on renal tubular epithelial cell injury induced by high glucose

International Journal of Molecular Sciences

Volumn 15, Issue 9, 2014, Pages 15026-15043

  Hou, Shaozhang ^a,b   Zheng, Fangfang ^a   Li, Yuan ^a   Gao, Ling ^a   Zhang, Jianzhong ^a,b  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b Ningxia Key Laboratory of Cerebrocranial Diseases   (China)

Author keywords

Diabetic nephropathy; Glycyrrhizic acid; NRK 52E

Indexed keywords

ANTIINFLAMMATORY AGENT; GLUCOSE; GLYCYRRHIZIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; PPARGC1A PROTEIN, RAT; REACTIVE OXYGEN METABOLITE; SIRT1 PROTEIN, RAT; SIRTUIN 1; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; DIABETIC NEPHROPATHY; DRUG EFFECTS; EPITHELIUM CELL; GENETICS; KIDNEY TUBULE; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; RAT; ULTRASTRUCTURE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DIABETIC NEPHROPATHIES; EPITHELIAL CELLS; GLUCOSE; GLYCYRRHIZIC ACID; KIDNEY TUBULES; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SIRTUIN 1; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84906842107     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150915026     Document Type: Article

References (28)

1. Giunti, S.; Barit, D.; Cooper, M.E. Diabetic nephropathy: From mechanisms to rational therapies. Minerva Med. 2006, 97, 241-262
2. Baoyu, T.; Xiaoli, C.; Yu, L. Oxidative stress in diabetic rat kidney and PGC-1α mRNA expression. Chin. J. Mod. Med. 2010, 7, 13-16
3. Hallows, K.R.; Mount, P.F.; Pastor-Soler, N.M.; Power, D.A. Role of the energy sensor AMP-activated protein kinase in renal physiology and disease. Am. J. Physiol. Ren. Physiol. 2010, 298, F1067-F1077
4. Fornoni, A.; Ijaz, A.; Tejada, T. Role of inflammation in diabetic nephropathy. Curr. Diabetes Rev. 2008, 4, 10-17
5. Ming, M.J.; Yin, A.C. Therapeutic effects of glycyrrhizic acid. Nat. Prod. Commun. 2013, 8, 415-418
6. Lee, C.H.; Park, S.W.; Kim, Y.S.; Kang, S.S.; Kim, J.A.; Lee, S.H.; Lee, S.M. Protective Mechanism of Glycyrrhizic acid on acute liver injury induced by carbon tetrachloride in mice. Biol. Pharm. Bull. 2007, 30, 1898-1904
7. Subramanian, S.; Bowyer, M.W.; Egan, J.C.; Knolmayer, T.J. Atenuation of renal is chemia-reperfusion injury with selectin inhibition in rabbit model. Am. J. Surg. 2009, 178, 573-576
8. Zhang, J.; Jing, L.; Hou, S.; Ge, X.; Zhao, L.; Qin, H.; Guo, F. Effect of glycyrrhizin on kidney of diabetic rats TGF-β1 expression (in Chinese). Chin. J. Clin. Pharmacol. 2010, 26, 673-676
9. Sodhi, C.P.; Phadke, S.A.; Batlle, D.; Sahai, A. Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: Role of osteopontin. Am. J. Physiol. Ren. Physiol. 2011, 280, 667-774
10. Suzaki, Y.; Yoshizumi, M.; Kagami, S.; Nishiyama, A.; Ozawa, Y.; Kyaw, M.; Izawa, Y.; Kanematsu, Y.; Tsuchiya, K.; Tamaki, T. BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions. Kidney Int. 2004, 65, 1749-1760
11. Jilin, W.; Wei, L.; Xuexia, L. Effect of ganoderma on rat mesangial cells proliferation and cell cycle cultured in high glucose (in Chinese). Integr. Med. China 2008, 9, 61-63
12. Forbes, J.M.; Coughlan, M.T.; Cooper, M.E. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008, 57, 1446-1454
13. Singh, D.K.; Winocour, P.; Farrington, K. Oxidative stress in early diabetic nephropathy: Fueling the fire. Nat. Rev. Endocrinol. 2011, 7, 176-184
14. Dentelli, P.; Rosso, A.; Zeoli, A.; Gambino, R.; Pegoraro, L.; Pagano, G.; Falcioni, R.; Brizzi, M.F. Oxidative stress-mediated mesangial cell proliferation requires RAC-1/reactive oxygen species production and beta4 integrin expression. J. Biol. Chem. 2007, 282, 26101-26110
15. Toyokuni, S.; Tanaka, T.; Hattori, Y.; Nishiyama, Y.; Yoshida, A.; Uchida, K.; Hiai, H.; Ochi, H.; Osawa, T. Quantitative immunohistochemical determination of 8-hydroxy-20-deoxyguanosine by a monoclonal antibody N45.1: Its application to ferric nitrilotriacetateinduced renal carcinogenesis model. Lab. Investig. 1997, 76, 365-374
16. Karadeniz, A.; Simsek, N.; Karakus, E.; Yildirim, S.; Kara, A.; Can, I.; Kisa, F.; Emre, H.; Turkeli, M. Royal jelly modulates oxidative stress and apoptosis in liver and kidneys of rats treated with cisplatin. Oxid. Med. Cell. Longev. 2011, doi:10.1155/2011/981793
17. Jeong, H.G.; You, H.J.; Park, S.J. Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: Inhibition of cytochrome P450 2E1 expression. Pharmacol. Res. 2002, 46, 221-227
18. Liu, C.; Lin, J.D. PGC-1 coactivators in the control of energy metabolism. Acta Biochim. Biophys. Sin. 2011, 43, 248-257
19. Leone, T.C.; Lehman, J.J.; Finck, B.N.; Schaeffer, P.J.; Wende, A.R.; Boudina, S.; Courtois, M.; Wozniak, D.F.; Sambandam, N.; Bernal-Mizrachi, C., et al. PGC-1α deficiency causes multi-system energy metabolic derangements: Muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 2005, 3, e101
20. Tan, B.; Li, X.; Yin, Y.; Wu, Z.; Liu, C.; Tekwe, C.D.; Wu, G. Regulatory roles for L-arginine in reducing white adipose tissue. Front. Biosci. 2012, 17, 2237-2246
21. Liang, H.; Ward, W. F. PGC-1α: A key regulator of energy metabolism. Adv. Physiol. Educ. 2006, 30, 145-151
22. Cansby, E.; Nerstedt, A.; Amrutkar, M.; Duran, E.N.; Smith, U.; Mahlapuu, M. Partial hepatic resistance to IL-6-induced inflammation develops in type 2 diabetic mice, while the anti-inflammatory effect of AMPK is maintained. Mol. Cell Endocrinol. 2014, 393, 143-151
23. Namkoong, C.; Kim, M.S.; Jang, P.G.; Han, S.M.; Park, H.S.; Koh, E.H.; Lee, W.J.; Kim, J.Y.; Park, I.S.; Park, J.Y., et al. Enhanced hypothalamic AMP-activated protein kinase activity contributes to hyperphagia in diabetic rats. Diabetes 2005, 54, 63-68
24. Kume, S.; Uzu, T.; Araki, S.; Sugimoto, T.; Isshiki, K.; Chin-Kanasaki, M.; Sakaguchi, M.; Kubota N.; Terauchi, Y.; Kadowaki, T., et al. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J. Am. Soc. Nephrol. 2007, 18, 2715-2723
25. Kitada, M.; Kume, S.; Imaizumi, N.; Koya, D. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes 2011, 60, 634-643
26. Ruderman, N.B.; Xu, X.J.; Nelson, L.; Cacicedo, J.M.; Saha, A.K.; Lan, F.; Ido, Y. AMPK and SIRT1: A long-standing partnership? Am. J. Physiol. Endocrinol. Metab. 2010, 298, 751-760
27. Gerhart-Hines, Z.; Rodgers, J.T.; Bare, O.; Lerin, C.; Kim, S.H.; Mostoslavsky, R.; Alt, F.W.; Wu, Z.; Puigserver, P. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α. EMBO J. 2007, 26, 1913-1923
28. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 2006, 127, 1109-1122.